Document ID: chunk:federal_register_of_legislation:F2024C00671:reg:11:p2
Version: federal_register_of_legislation:F2024C00671
Segment Type: reg
Provision Reference: reg 11 (pt 2/2)
Character Range: 12943–15618

= Dictionary                               (prev…) = previously
disallowed = disallowed by Parliament           Pt = Part(s)
Div = Division(s)                               r = regulation(s)/rule(s)
ed = editorial change                           reloc = relocated
exp = expires/expired or ceases/ceased to have  renum = renumbered
effect                                          rep = repealed
F = Federal Register of Legislation             rs = repealed and substituted
gaz = gazette                                   s = section(s)/subsection(s)
LA = Legislation Act 2003                       Sch = Schedule(s)
LIA = Legislative Instruments Act 2003          Sdiv = Subdivision(s)
(md) = misdescribed amendment can be given      SLI = Select Legislative Instrument
effect                                          SR = Statutory Rules
(md not incorp) = misdescribed amendment        Sub‑Ch = Sub‑Chapter(s)
cannot be given effect                          SubPt = Subpart(s)
mod = modified/modification                     underlining = whole or part not
No. = Number(s)                                 commenced or to be commenced

Endnote 3—Legislation history

Name                                                                                                                     Registration               Commencement                                    Application, saving and transitional provisions
National Health (Chemotherapy Prescribing) Special Arrangement 2020 (PB 52 of 2020)                                      20 Aug 2020 (F2020L01038)  21 Aug 2020 (s 2(1) item 1)
National Health (Chemotherapy Prescribing) Consequential Amendments Special Arrangement 2021 (PB 117 of 2021)            31 Oct 2021 (F2021L01492)  1 Nov 2021 (s 2(1) item 1)                      —
National Health Legislation Amendment (Conditions of Approval for Approved Pharmacists) Instrument 2023 (PB 17 of 2023)  1 May 2023 (F2023L00511)   Sch 2 (item 1): 1 June 2023 (s 2(1) item 1)     —
National Health Legislation (Repeal and Consequential Amendments) Instrument 2024 (PB 36 of 2024)                        28 Mar 2024 (F2024L00412)  Sch 2 (items 1‑15): 1 Apr 2024 (s 2(1) item 1)  —

Endnote 4—Amendment history

Provision affected        How affected
s 2.....................  rep LA s 48D
s 4.....................  am F2024L00412
s 5.....................  am F2021L01492; F2024L00412
s 6.....................  am F2024L00412
s 8.....................  rs F2024L00412
s 9.....................  rs F2024L00412
s 10....................  am F2024L00412
s 11....................  rs F2024L00412
s 12....................  am F2023L00511
                          rep F2024L00412